[email protected]   |     +91 7428116100   |    Mon – Sat, 9AM – 5 PM 

Book Sample

[email protected]   |    +91 7428116100

CONTACT US

[email protected]
+91 7428116100 

Book Sample

Clinical Research - Clinical Data Management and Statistical Analysis

At Auriga Research Private Limited, we deliver top-tier Clinical Data Management (CDM) and Statistical Analysis services, ensuring data integrity and precision throughout the clinical trial process. Our expertise is fundamental to securing successful clinical trial outcomes and achieving regulatory approvals, helping pharmaceutical companies meet compliance requirements effectively.

What is Clinical Data Management and Statistical Analysis?

Clinical Data Management (CDM) and Statistical Analysis are essential components in clinical research, facilitating the generation of high-quality and reliable data to support critical decision-making.

  • Data Management: Focuses on the systematic collection, organization, validation, and maintenance of trial data to ensure its accuracy and accessibility.
  • Statistical Analysis: Applies advanced statistical methodologies to interpret clinical data, transforming raw data into clear, evidence-based conclusions for decision-making.

Why is Clinical Data Management and Statistical Analysis Essential?

Patient Safety

Pharmacovigilance ensures the ongoing safety of patients by monitoring adverse drug reactions (ADRs) and other drug-related issues. It involves rigorous assessment of the safety data to detect potential risks early.

Patient Safety

Pharmacovigilance ensures the ongoing safety of patients by monitoring adverse drug reactions (ADRs) and other drug-related issues. It involves rigorous assessment of the safety data to detect potential risks early.

Regulatory Compliance

Compliance with national and international regulatory requirements, such as those established by the FDA, EMA, DCGI, and PVPI, is critical. Pharmacovigilance activities are essential to meet these regulatory obligations, which are pivotal for market authorization and continued marketing of pharmaceutical products.

Regulatory Compliance

Compliance with national and international regulatory requirements, such as those established by the FDA, EMA, DCGI, and PVPI, is critical. Pharmacovigilance activities are essential to meet these regulatory obligations, which are pivotal for market authorization and continued marketing of pharmaceutical products.

Market Authorization

Robust pharmacovigilance systems support the approval and ongoing authorization of pharmaceutical products by providing necessary safety data and demonstrating effective risk management.

Market Authorization

Robust pharmacovigilance systems support the approval and ongoing authorization of pharmaceutical products by providing necessary safety data and demonstrating effective risk management.

Risk Management

Effective PV systems help in identifying, assessing, and mitigating risks associated with drug use, thereby improving patient outcomes and public health.

Risk Management

Effective PV systems help in identifying, assessing, and mitigating risks associated with drug use, thereby improving patient outcomes and public health.

Key Activities in Clinical Data Management and Statistical Analysis

Data Management and Statistical Analysis
Adverse Event Reporting
This involves the systematic collection, analysis, and submission of individual case safety reports (ICSRs) for adverse events to regulatory authorities. Timely reporting is crucial to mitigate risks associated with medicinal products.

Data Management and Statistical Analysis
Periodic Safety Update Reports (PSURs)
Regular updates to regulatory authorities on the safety profile of a drug, providing a comprehensive evaluation of the benefit-risk balance over defined periods.

Data Management and Statistical Analysis
Risk Management Plans (RMPs)
Detailed strategies to identify, assess, and mitigate risks associated with medicinal products. RMPs outline the measures to minimize risks and monitor their effectiveness.

Data Management and Statistical Analysis
Signal Detection and Evaluation
Continuous monitoring for new safety signals and assessing their potential impact. This involves advanced statistical methods and data mining techniques to detect emerging safety issues.

Data Management and Statistical Analysis
Literature Surveillance
Ongoing review of scientific literature to identify any new information related to drug safety, ensuring all emerging safety data is captured and analyzed promptly.

Data Management and Statistical Analysis
Benefit-Risk Assessment
Regular evaluation of the benefits and risks of a drug to ensure a positive benefit-risk balance, guiding informed decision-making.

How We Manage Clinical Data Management and Statistical Analysis Activities

Data Management and Statistical Analysis
At Auriga Research Private Limited, we follow a structured and technology-driven approach to manage clinical data and ensure robust statistical analysis
  • Integrated Technology Solutions – We utilize advanced Electronic Data Capture (EDC) systems and Clinical Data Management Systems (CDMS) to streamline data management, ensuring efficiency and accuracy in handling clinical trial data.
  • Expertise in Biostatistics – Our expert biostatisticians use sophisticated SAS and other statistical tools to ensure clear, precise analysis and accurate reporting for clinical trials.
  • Rigorous Training and Development – We continuously update our team’s skills in alignment with the latest industry standards, ensuring they stay abreast of regulatory changes and advancements in clinical trial technologies
  • Strict Adherence to Regulatory Standards – We rigorously comply with Good Clinical Practice (GCP), ICH guidelines, and 21 CFR Part 11, ensuring full regulatory adherence across all processes.
  • Proactive Data Monitoring – We provide real-time monitoring of trial data to quickly identify, address, and resolve any potential issues, ensuring trial integrity is maintained at every stage.

Software Features

Our pharmacovigilance services are supported by robust software features that enhance efficiency and accuracy:

Data Management and Statistical Analysis

Automated Case Processing

Streamlined workflows for faster and more accurate case processing.

 

Data Management and Statistical Analysis

Real-Time
Monitoring

Immediate detection and reporting of adverse events, ensuring timely action.

 

Data Management and Statistical Analysis

Data
Integration

Seamless integration with other systems for comprehensive safety data management.

 

Data Management and Statistical Analysis

Advanced
Analytics

In-depth analysis and visualization tools for better decision-making.

 

Data Management and Statistical Analysis

User-Friendly
Interfaces

Intuitive designs simplify navigation and management for all stakeholders.

 

Regulatory Requirements

DOMESTIC

We ensure that all our Clinical Data Management and Statistical Analysis services comply with domestic regulations, including:

  • CDSCO Compliance: Ensuring that all data management and reporting practices align with the standards set by India’s Central Drugs Standard Control Organization (CDSCO).
  • Adherence to Local Laws: We strictly follow all relevant local regulations regarding data protection, clinical trial conduct, and documentation requirements, ensuring trials remain compliant at every step.

INTERNATIONAL

Our services extend to ensuring global regulatory compliance for international clinical trials:

  • Global Compliance: We meet international standards set by major regulatory bodies, including the FDA and EMA, ensuring seamless regulatory submissions and approvals.
  • Audit Preparedness: We maintain audit-ready documentation and processes that are fully compliant with international guidelines, preparing our clients for potential inspections from global regulators.